Correction: Distribution and outcomes of a phenotype-based approach to guide COPD management: Results from the CHAIN cohort (PLoS ONE (2016) 11:9 (e0160770) DOI: 10.1371/journal.pone.0160770);Distribution and outcomes of a phenotype-based approach to guide COPD management: Results from the CHAIN cohort

PLoS ONE

Volumn 11, Issue 9, 2016, Pages

  Cosio, Borja G ^a,b   Soriano, Joan B ^c   López Campos, Jose Luis ^b,d   Calle, Myriam ^e   Soler, Juan José ^b,f   De Torres, Juan Pablo ^g   Marín, Jose Maria ^b,h   Martínez, Cristina ⁱ   De Lucas, Pilar ^j   Mir, Isabel ^k   Peces Barba, Germán ^b,l   Feu Collado, Nuria ^m   Solanes, Ingrid ⁿ   Alfageme, Inmaculada ^o,p   Bonachera, José Calvo ^q   Bautista, Celia Lacárcel ^r   Domenech, Adolfo ^s   Guzmán, Rosirys ⁱ   Irigaray, Rosa ^t   Zamora, Meritxell López ^a   Ríos, Angel ^a   Córdova, Rocío ^a   Viladrich, Isabel Mir ^k   López, Carlos Cabrera ^u   Acosta, Alejandro Sánchez ^v   González, Juan Abreu ^w   Balbin, Ramón Agüero ^x   Balcells, Eva ^y   Campos, Elena Miguel ^z   Marin, Alicia ^aa   Casanova, Antonia Llunel ^ab   Moreno, Amalia ^ac   Pérez, Francisca Lourdes Márquez ^ad   Miranda, Juan Antonio Riesco ^ae   Rodríguez, Julia Tabara ^af   Gómez, Rafael Golpe ^ag   De Miguel Díez, Javier ^j   Río, Francisco García ^ah   Lobato, Salvador Díaz ^ai   Iturri, Juan Bautista Galdiz ^aj   Royo, Margarita Marín ^ak   De Diego Damia, Alfredo ^al   more..

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^e HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^f HOSPITAL ARNAU DE VILANOVA   (Spain)

^g UNIVERSITY CLINIC OF NAVARRA   (Spain)

^h HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

ⁱ HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^j HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^k HOSPITAL SON LLÀTZER   (Spain)

^l Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^m UNIVERSITY OF CÓRDOBA   (Spain)

ⁿ HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^o HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^p HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^q Hospital de Torrecardenas   (Spain)

^r Hosp Univ Ciudad de Jaén   (Spain)

^s HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^t HOSPITAL DE MANACOR   (Spain)

^u HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^v HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^w HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^x HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^y HOSPITAL DEL MAR   (Spain)

^z Unidad de Cuidados Intensivos Hospital Sant Joan Despi Moisés Broggi   (Spain)

^aa HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^ab HOSPITAL DE TERRASSA   (Spain)

^ac Hospital Parc Tauli   (Spain)

^ad HOSPITAL INFANTA CRISTINA   (Spain)

^ae HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

^af HOSPITAL JUAN CANALEJO   (Spain)

^ag Calde General Hospital Lugo   (Spain)

^ah HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^ai HOSPITAL RAMÓN Y CAJAL   (Spain)

^aj HOSPITAL DE CRUCES   (Spain)

^ak HOSPITAL GENERAL DE CASTELLÓN   (Spain)

^al HOSPITAL UNIVERSITARIO LA FE   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PHENOTYPE; TREATMENT PLANNING;

EID: 84991783834     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0166257     Document Type: Erratum

References (23)

1. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187: 347-365. rccm.201204-0596PP [pii]; doi: 10.1164/rccm.201204-0596PP PMID: 22878278
2. Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, et al. (2010) Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 182: 598-604. 200912-1843CC [pii]; doi: 10.1164/rccm.200912-1843CC PMID: 20522794
3. Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, et al. (2010) Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363: 1128-1138. doi: 10.1056/NEJMoa0909883 PMID: 20843247
4. Hardin M, Silverman EK, Barr RG, Hansel NN, Schroeder JD, Make BJ, et al. (2011) The clinical features of the overlap between COPD and asthma. Respir Res 12: 127. 1465-9921-12-127 [pii]; doi: 10.1186/1465-9921-12-127 PMID: 21951550
5. Pascoe S, Locantore N, Dransfield MT, Barnes NC, Pavord ID (2015) Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med 3: 435-442. S2213-2600(15)00106-X [pii]; doi: 10.1016/S2213-2600(15)00106-X PMID: 25878028
6. Calverley PM, Rabe KF, Goehring UM, Kristiansen S, Fabbri LM, Martinez FJ (2009) Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet 374: 685-694. doi: 10.1016/S0140-6736(09)61255-1 PMID: 19716960
7. Miravitlles M, Soler-Cataluna JJ, Calle M, Molina J, Almagro P, Quintano JA, et al. (2014) Spanish guideline for COPD (GesEPOC). Update 2014. Arch Bronconeumol 50 Suppl 1: 1-16. S0300-2896(14)70070-5 [pii]; doi: 10.1016/S0300-2896(14)70070-5 PMID: 24507959
8. Miravitlles M, Barrecheguren M, Roman-Rodriguez M (2015) Frequency and characteristics of different clinical phenotypes of chronic obstructive pulmonary disease. Int J Tuberc Lung Dis 19: 992-998. doi: 10.5588/ijtld.15.0021 PMID: 26162367
9. Lopez-Campos JL, Peces-Barba G, Soler-Cataluna JJ, Soriano JB, de Lucas RP, de-Torres JP, et al (2012) Chronic obstructive pulmonary disease history assessment in Spain: a multidimensional chronic obstructive pulmonary disease evaluation. Study methods and organization. Arch Bronconeumol 48: 453-459. S0300-2896(12)00203-7 [pii]; doi: 10.1016/j.arbres.2012.05.006 PMID: 22766419
10. Celli B.R., MacNee W. and committee members (2004) Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23: 932-946. doi: 10.1183/09031936.04.00014304 PMID: 15219010
11. Celli BR, Cote CG, Marin JM, Casanova C, Montes de OM, Mendez RA, et al. (2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350: 1005-1012. doi: 10.1056/NEJMoa021322 PMID: 14999112
12. Cosio BG, Soriano JB, Lopez-Campos JL, Calle-Rubio M, Soler-Cataluna JJ, de-Torres JP, et al. (2016) Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort. Chest 149: 45-52. S0012-3692(15)00137-3 [pii]; doi: 10.1378/chest.15-1055 PMID: 26291753
13. Soler-Cataluna JJ, Martinez-Garcia MA, Roman SP, Salcedo E, Navarro M, Ochando R (2005) Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60: 925-931. doi: 10.1136/thx.2005.040527 PMID: 16055622
14. Bateman ED, Reddel HK, van Zyl-Smit RN, Agusti A (2015) The asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases? Lancet Respir Med 3: 719-728. S2213-2600(15)00254-4 [pii]; doi: 10.1016/S2213-2600(15)00254-4 PMID: 26255108
15. Kim V, Han MK, Vance GB, Make BJ, Newell JD, Hokanson JE, et al. (2011) The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. Chest 140: 626-633. chest.10-2948 [pii]; doi: 10.1378/chest.10-2948 PMID: 21474571
16. Menezes AM, Montes de OM, Perez-Padilla R, Nadeau G, Wehrmeister FC, Lopez-Varela MV, et al. (2014) Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest 145: 297-304. S0012-3692(15)34169-6 [pii]; doi: 10.1378/chest.13-0622 PMID: 24114498
17. Johannessen A, Skorge TD, Bottai M, Grydeland TB, Nilsen RM, Coxson H, et al. (2013) Mortality by level of emphysema and airway wall thickness. Am J Respir Crit Care Med 187: 602-608. rccm.201209-1722OC [pii]; doi: 10.1164/rccm.201209-1722OC PMID: 23328525
18. Garcia-Aymerich J, Gomez FP, Benet M, Farrero E, Basagana X, Gayete A, et al. (2011) Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax 66: 430-437. thx.2010.154484 [pii]; doi: 10.1136/thx.2010.154484 PMID: 21177668
19. Burgel PR, Paillasseur JL, Peene B, Dusser D, Roche N, Coolen J, et al. (2012) Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortality. PLoS One 7: e51048. doi: 10.1371/journal.pone.0051048 PONE-D-12-21840 [pii]. PMID: 23236428
20. Rennard SI, Locantore N, Delafont B, Tal-Singer R, Silverman EK, Vestbo J, et al. (2015) Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis. Ann Am Thorac Soc 12: 303-312. doi: 10.1513/AnnalsATS.201403-125OC PMID: 25642832
21. Miravitlles M, Soler-Cataluna JJ, Calle M, Molina J, Almagro P, Quintano JA, et al. (2013) A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC). Prim Care Respir J 22: 117-121. pcrj-2012-11-0159-R1 [pii]; doi: 10.4104/pcrj.2013.00016 PMID: 23443227
22. Koblizek V, Chlumsky J, Zindr V, Neumannova K, Zatloukal J, Zak J, et al. (2013) Chronic Obstructive Pulmonary Disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 157: 189-201. doi: 10.5507/bp.2013.039 PMID: 23733084
23. Soriano JB, Lamprecht B, Ramirez AS, Martinez-Camblor P, Kaiser B, Alfageme I, et al. (2015) Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data. Lancet Respir Med 3: 443-450. S2213-2600(15)00157-5 [pii]; doi: 10.1016/S2213-2600(15)00157-5 PMID: 25995071